Diagnostic biomarkers of ischemic stroke: strengths and limitations across blood, urine, and saliva

Begüm Utz, Pihla Miettinen, Ivette Bañuelos-Cabrera, Leonardo Lara-Valderrábano, Lasse Välimaa, Adrian Harel · 2026

Read Diagnostic biomarkers of ischemic stroke: strengths and limitations across blood, urine, and saliva by Begüm Utz, Pihla Miettinen, Ivette Bañuelos-Cabrera, Leonardo Lara-Valderrábano, Lasse Välimaa, Adrian Harel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318703.txt.

Description

Begüm Utz and co-authors review, in 2026, diagnostic biomarkers for ischaemic stroke. Brain imaging is the standard test, but scanners are often missing before hospital arrival. A fast body-fluid test could confirm stroke and separate it from bleeding or mimics. The review sorts markers from blood, urine, and saliva by pathway.

Blood markers are the most advanced so far. One brain protein, glial fibrillary acidic protein, shows high specificity for early subtyping. Many other markers rise too slowly or lack specificity. Urine and saliva signatures exist but remain experimental and unvalidated in large acute groups. No single marker suffices, the authors conclude. They back multi-marker panels with standard methods and early sampling.

Catalog record

CREATORBegüm Utz, Pihla Miettinen, Ivette Bañuelos-Cabrera, Leonardo Lara-Valderrábano, Lasse Välimaa, Adrian Harel
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48112
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13318703

Browse the full library · About the Tower of Babel